Department of Urology, University of Tübingen, Tübingen, Germany.
Englander Institute for Precision Medicine, Sandra and Edward Meyer Cancer Center, New York, NY, USA.
BJU Int. 2022 Sep;130(3):291-300. doi: 10.1111/bju.15662. Epub 2022 Jan 17.
To describe the use of artificial intelligence (AI) in medical literature and trial data extraction, and its applications in uro-oncology. This bridging review, which consolidates information from the diverse applications of AI, highlights how AI users can investigate more sophisticated queries than with traditional methods, leading to synthesis of raw data and complex outputs into more actionable and personalised results, particularly in the field of uro-oncology.
Literature and clinical trial searches were performed in PubMed, Dimensions, Embase and Google (1999-2020). The searches focussed on the use of AI and its various forms to facilitate literature searches, clinical guidelines development, and clinical trial data extraction in uro-oncology. To illustrate how AI can be applied to address questions about optimising therapeutic decision making and individualising treatment regimens, the Dimensions-linked information platform was searched for 'prostate cancer' keywords (76 publications were identified; 48 were included).
AI offers the promise of transforming raw data and complex outputs into actionable insights. Literature and clinical trial searches can be automated, enabling clinicians to develop and analyse publications expeditiously on complex issues such as therapeutic sequencing and to obtain updates on documents that evolve at the pace and scope of the landscape. An AI-based platform inclusive of 12 trial databases and >100 scientific literature sources enabled the creation of an interactive visualisation.
As the literature and clinical trial landscape continues to grow in complexity and with increasing speed, the ability to pull the right information at the right time from different search engines and resources, while excluding social media bias, becomes more challenging. This review demonstrates that by applying natural language processing and machine learning algorithms, validated and optimised AI leads to a speedier, more personalised, efficient, and focussed search compared with traditional methods.
描述人工智能(AI)在医学文献和试验数据提取中的应用,以及其在泌尿肿瘤学中的应用。本综述整合了 AI 各种应用的信息,展示了 AI 用户如何能够调查比传统方法更复杂的查询,从而将原始数据和复杂结果综合为更具可操作性和个性化的结果,特别是在泌尿肿瘤学领域。
在 PubMed、Dimensions、Embase 和 Google 上进行文献和临床试验检索(1999-2020 年)。检索重点是使用 AI 及其各种形式来促进文献检索、临床指南制定以及泌尿肿瘤学临床试验数据提取。为了说明 AI 如何应用于解决优化治疗决策和个体化治疗方案的问题,在 Dimensions 链接的信息平台上搜索了“前列腺癌”关键词(确定了 76 篇出版物;纳入了 48 篇)。
AI 有望将原始数据和复杂结果转化为可操作的见解。文献和临床试验搜索可以实现自动化,使临床医生能够快速开发和分析复杂问题(如治疗方案的排序)的出版物,并及时获取不断演变的文献的更新。一个包含 12 个试验数据库和>100 个科学文献源的基于 AI 的平台能够创建一个交互式可视化。
随着文献和临床试验领域的复杂性和速度不断增加,从不同搜索引擎和资源中在正确的时间提取正确信息,同时排除社交媒体偏见的能力变得更加具有挑战性。本综述表明,通过应用自然语言处理和机器学习算法,经过验证和优化的 AI 与传统方法相比,可实现更快、更个性化、更高效和更有针对性的搜索。